Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Evaluating radiological criteria for stability in wrist fractures

Official title: Radiological Criteria for Instability in Distal Radius Fractures

Run by Oslo University Hospital · NCT06617780 · Data updated 2026-11-12

This study tests if certain X-ray and CT scan results can help doctors decide if adults with wrist fractures need surgery after a closed reduction.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment212 (estimated)
SponsorOslo University Hospital
Academic / other
Locations1 site (Oslo, Oslo)
StatusRecruiting
StartedOctober 7, 2024
Main results expectedOctober 7, 2026
Study endsApril 2027
Registry record updatedAugust 12, 2026
Trial IDNCT06617780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 65 with specific types of dorsally displaced distal radius fractures.

Probably not a fit

Patients with volar comminution, open fractures, or significant prior wrist injuries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the radiological criteria that can indicate whether a dorsally displaced distal radius fracture remains stable after closed reduction. It focuses on patients aged 18 to 65 years and aims to establish criteria that could help determine if surgical intervention is necessary. The study involves X-ray imaging after three months and CT scans the day after the closed reduction procedure to assess fracture stability. The goal is to improve treatment decisions and outcomes for patients with wrist fractures.

Why it matters

Potential benefit: If successful, this study could lead to more accurate assessments of fracture stability, potentially reducing unnecessary surgeries and improving patient outcomes.

How similar studies have gone: While there have been attempts to establish criteria for fracture stability, this study addresses a gap in standardization and could provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criterias:

* 18-65 years old, living in Oslo/surroundings (available for follow-up)
* AO class A2/3 or C1/C2 fractures
* Dorsally displaced fracture of the distal radius (minimum VLDV more than100 or ulnar variance more than 2 mm compared to healthy side before reduction) with or without PSU fracture
* Reduced to an acceptable position (VLDV 75-95 degrees, RIV more than 15 degrees, ulnar variance more than 2 mm, step/diastasis in the joint surface less than 2 mm)

Exclution criterias:

* Volar comminution (AO A3.3), step/diastasis more than 2 mm before reduction
* Ad latus more than 2 cortex widths after reduction
* Bilateral fractures
* Open fractures
* Previous wrist fracture in adulthood
* Still open growth disc on X-ray
* Antebrachium or carpal fracture
* Ligament damage in the root of the hand or DRUJ
* Lack of compliance (dementia, psychiatry/drug abuse, etc.)
* Language problems
* Rheumatoid arthritis or other systemic disease that can affect the result

Where it's running

  • Oslo University Hospital, Aker, Oslo Skadelegevakt
    Oslo, Oslo, Norway
    Recruiting

Study contacts

  • Principal investigator: Lene B. Solberg, PhD MD — Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway
  • Study coordinator: Lene B. Solberg, PhD MD
  • Email: l.b.solberg@gmail.com
  • Phone: +47 97669950

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.